Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome
- Conditions
- NAFLDMetabolic Syndrome
- Registration Number
- NCT06398522
- Lead Sponsor
- University of Bologna
- Brief Summary
This was a double-blind, randomized, placebo-controlled clinical study aiming to assess the effect of a food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3 on liver steatosis in individuals with NAFLD and metabolic syndrome
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Effect on Fatty Liver Index 3 months We evaluated the effect on Fatty Liver Index (FLI) of 3-month assumption of a food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3, compared to either baseline and placebo
- Secondary Outcome Measures
Name Time Method Effect on Hepatic Steatosis Index 3 months We evaluated the effect on Hepatic Steatosis Index (HSI) of 3-month assumption of a food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3, compared to either baseline and placebo
Effect on Lipid Accumulation Product 3 months We evaluated the effect on Lipid Accumulation Product (LAP) of 3-month assumption of a food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3, compared to either baseline and placebo
Trial Locations
- Locations (1)
University of Bologna
🇮🇹Bologna, BO, Italy
University of Bologna🇮🇹Bologna, BO, Italy